Alpha Tau Medical Cash Flow Statement (2020-2025) | DRTS

Cash Flow Statement Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter)
11.69M6.95M4.81M3.81M25.74M1.99M2.60M3.39M8.14M8.64M4.99M7.35M7.98M7.36M6.92M9.47M8.49M9.98M11.70M12.21M
Depreciation and Depletion (Quarter)
0.16M0.23M0.24M
Gains from Sales and Divestitures (Quarter)
0.23M0.45M0.69M0.86M
Gains from Investment Securities (Quarter)
0.04M5.33M8.24M1.19M4.17M10.97M
Non-cash Items (Quarter)
2.28M1.12M6.46M9.56M12.33M
Cash from Operations (Quarter)
-3.13M-6.58M-8.74M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.16M0.23M0.24M
Change in Working Capital
Change in Account Payables (Quarter)
0.07M2.63M-2.63M
Change in Accured Expenses (Quarter)
-0.40M3.20M-0.98M1.57M2.04M2.25M2.43M2.78M3.12M3.47M3.49M3.41M2.82M4.13M6.19M4.68M4.97M5.51M
Other Working Capital Changes (Quarter)
-0.31M-3.45M1.00M
Investing Activities
Capital Expenditures (Quarter)
-0.61M-0.30M-0.38M
Cash from Investing Activities (Quarter)
-0.61M-0.30M-92.38M
Financing Activities
Other financing activities (Quarter)
0.14M1.98M1.46M
Cash from Financing Activities (Quarter)
0.00M81.98M14.81M
Additional items
Exchange Rate Effect (Quarter)
-0.56M-0.05M-0.24M
Change in Cash (Quarter)
-4.30M75.05M-86.55M
Beginning Cash Balance (Quarter)
16.17M23.85M
Free Cash Flow (Quarter)
-2.52M-6.29M-8.37M
Net Cash Flow (Quarter)
-3.74M75.10M-86.31M